Cardiovascular Biomarkers and Quetiapine in Depression and Anxiety Patients

Summary

No suitable treatment has been identified to reverse and ideally prevent, the cardiovascular disease risk associated with depression and anxiety. The purpose of this study is to determine if quetiapine treatment of depression can reverse the signs of arterial stiffening that often occurs in depression and anxiety, and which are believed to be risk factors for future heart disease.

Timeline

Start

2009-07

Primary completion

2011-10

Completion

2011-10

Drugs

Indications